Ignite Creation Date:
2025-12-25 @ 12:24 AM
Ignite Modification Date:
2026-01-06 @ 9:23 AM
Study NCT ID:
NCT01939158
Status:
COMPLETED
Last Update Posted:
2021-10-05
First Post:
2013-08-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Immunogenicity and Safety Study of 1 and 2 Doses of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine MenACWY-TT (GSK134612) in Toddlers, Persistence up to 5 Years After Vaccination and Co-administration With Pfizer's Prevenar 13™Vaccine
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-02
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-05
Completion Date Type:
ACTUAL
First Submit Date:
2013-08-29
First Submit QC Date:
None
Study First Post Date:
2013-09-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-09-07
Results First Submit QC Date:
None
Results First Post Date:
2021-10-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-09-30
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-09-07
Last Update Post Date:
2021-10-05
Last Update Post Date Type:
ACTUAL